Voiding Efficiency, a Predictor of CIC

Trial Profile

Voiding Efficiency, a Predictor of CIC

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2018

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 06 Feb 2018 Planned end date changed from 31 Dec 2017 to 31 Dec 2018.
    • 06 Feb 2018 Planned primary completion date changed from 31 Dec 2017 to 31 Dec 2018.
    • 03 Jul 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top